Recovery From COVID-19–Related Disruptions in Cancer Detection
This cross-sectional study of nationally representative registry data found that cancer incidence recovered meaningfully in 2021 following substantial disruptions in 2020. However, incidence rates need to recover further to address the substantial number of patients with undiagnosed cancer during the pandemic.
Authors
- Uriel Kim (ORCID: https://orcid.org/0000-0001-9910-0682)
- Siran M. Koroukian (ORCID: https://orcid.org/0000-0002-8106-9581)
- Bryan T. Carroll (ORCID: https://orcid.org/0000-0001-5712-6307)
- Jeremy S. Bordeaux (ORCID: https://orcid.org/0000-0002-7010-7730)
- Richard S. Hoehn (ORCID: https://orcid.org/0000-0003-1455-6758)
- Johnie Rose (ORCID: https://orcid.org/0000-0001-7458-9303)
- Eric Yu Hai Chen (ORCID: https://orcid.org/0000-0002-5247-3593)
Institutions
- Cedars-Sinai Medical Center (US)
- University of California, Irvine (US)
- University Hospitals of Cleveland (US)
- Case Western Reserve University (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2024-10-14
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.39263
- Citations
- 14
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 3.96
Funders
- American Association for Cancer Research
- Celgene
- Cleveland Clinic
- Cleveland Clinic Foundation
- National Institutes of Health
- Centers for Disease Control and Prevention